Zn(2+)/Finding
One finding, on its own
A single claim from the graph, with the evidence strength computed from its study, the sentence it was drawn from, and the paper. This address does not change.
No detected effect on adverse event occurrence (oral or enteral supplement)
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.FindingNull result“The meta-analysis of adverse event rates showed no statistically significant difference between the zinc supplementation group and the placebo group (odds ratio [OR] = 2.536; 95% CI = 0.78 to 8.26; p = 0.122; I2 = 0%) Figure 9.”
Quoted verbatim from Efficacy of Zinc Supplementation in the Management of Primary Dysmenorrhea: A Systematic Review and Meta-Analysis.. - Study
- meta-analysis
- Population
- Women aged 13 to 27 years with primary dysmenorrhea; pooled across six randomised trials of zinc supplementation (gluconate or sulfate) against placebo
Effect 2.536 odds ratio, 95% CI 0.78 to 8.26
Efficacy of Zinc Supplementation in the Management of Primary Dysmenorrhea: A Systematic Review and Meta-Analysis.2024PMID:39683510Industry fundedPermalink
Keep reading
- Everything the graph holds on Zn(2+)
- Every compound studied against Adverse event occurrence (oral or enteral supplement)
- How to read the evidence strength and the marks
To cite this finding: https://catalystproject.ai/e/01M4PT625V5B7230Q6SKT48HJF